Lulizumab pegol
- Generic Name
- Lulizumab pegol
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 1421830-13-8
- Unique Ingredient Identifier
- LCT264LTYE
- Background
Lulizumab pegol is under investigation in clinical trial NCT02843659 (Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome).
- Associated Conditions
- -
- Associated Therapies
- -
Treg Modulation With CD28 and IL-6 Receptor Antagonists
- Conditions
- Interventions
- First Posted Date
- 2019-08-26
- Last Posted Date
- 2024-10-09
- Target Recruit Count
- 24
- Registration Number
- NCT04066114
- Locations
- 🇺🇸
Cleveland Clinic Foundation: Transplantation, Cleveland, Ohio, United States
🇺🇸University of California San Francisco School of Medicine: Transplantation, San Francisco, California, United States
🇺🇸University of Alabama School of Medicine: Transplantation, Birmingham, Alabama, United States
Relative Bioavailability of BMS-931699 From Prefilled Syringe Compared to Drug in Vial
- First Posted Date
- 2017-02-23
- Last Posted Date
- 2017-12-20
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 5
- Registration Number
- NCT03058822
- Locations
- 🇺🇸
Qps-Mra, Llc, South Miami, Florida, United States
Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
- Conditions
- Interventions
- First Posted Date
- 2016-07-26
- Last Posted Date
- 2018-10-04
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 45
- Registration Number
- NCT02843659
- Locations
- 🇺🇸
Arthritis And Osteoporosis Associates, Pa, Freehold, New Jersey, United States
🇺🇸Acme Research, Llc, Orangeburg, South Carolina, United States
🇺🇸West Tennessee Research Institute, Jackson, Tennessee, United States
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
- First Posted Date
- 2014-10-16
- Last Posted Date
- 2019-10-07
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 730
- Registration Number
- NCT02265744
- Locations
- 🇺🇸
The Arthritis Center, Palm Harbor, Florida, United States
🇺🇸Coeur D'Alene Arthrit Clin, Coeur d'Alene, Idaho, United States
🇺🇸Heartland Research Associates, Llc, Wichita, Kansas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.